DrugId:  1
1. Name:  SPK-843
2. Groups:  Investigational
3. Description:  SPK-843 has been used in trials studying the treatment of Cryptococcosis or Aspergillosis Infections.
4. Indication:  Not Available
DrugId:  2
1. Name:  Tyloxapol
2. Groups:  Approved, Investigational
3. Description:  Tyloxapol is a non-ionic detergent often used as a surfactant.
4. Indication:  Used as a surfactant to aid liquefaction and removal of mucopurulent (containing mucus and pus) bronchopulmonary secretions, administered by inhalation through a nebulizer or with a stream of oxygen. Also investigated for use/treatment in cystic fibrosis and pediatric indications.
DrugId:  3
1. Name:  RP01
2. Groups:  Investigational
3. Description:  RP01 is a novel anti-IgE immunotherapy for allergic individuals. It is designed to induce the immune system to produce antibodies that block Immunoglobulin E (IgE), the key mediator of an allergic response. It could offer benefit to millions of asthma and allergy patients.
4. Indication:  Investigated for use/treatment in allergic reaction and asthma.
DrugId:  4
1. Name:  Trichophyton verrucosum
2. Groups:  Approved
3. Description:  Trichophyton verrucosum is a fungus which can provoke allergic reactions. Trichophyton verrucosum extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  5
1. Name:  Ravuconazole
2. Groups:  Investigational
3. Description:  Not Available
4. Indication:  Investigated for use/treatment in fungal infections, aspergillosis, candidiasis, and onychomycosis.
DrugId:  6
1. Name:  Piclamilast
2. Groups:  Experimental
3. Description:  Piclamilast (RP-73,401), is a selective PDE4 inhibitor. It is comparable to other PDE4 inhibitors for its anti-inflammatory effects. It has been investigated for its applications to the treatment of conditions such as chronic obstructive pulmonary disease, bronchopulmonary dysplasia and asthma. It is a second generation compound that exhibits structural functionalities of the PDE4 inhibitors cilomilast and roflumilast. The structure for piclamilast was first elucidated in a 1995 European patent application.
4. Indication:  Not Available
DrugId:  7
1. Name:  TNX-901
2. Groups:  Investigational
3. Description:  TNX-901 is a therapeutic monoclonal antibodies designed to address significant unmet medical needs in the areas of asthma, allergy, inflammation and other diseases affecting the human immune system.
4. Indication:  Investigated for use/treatment in allergic reaction.
DrugId:  8
1. Name:  CAT-213
2. Groups:  Investigational
3. Description:  CAT-213 is a fully human anti-eotaxin monoclonal antibody with potential in the treatment of allergic disorders, has moved into pre-clinical development. It is developed by MedImmune for the treatment of Allergic Rhinitis.
4. Indication:  Investigated for use/treatment in allergic rhinitis.
DrugId:  9
1. Name:  Q-Derp1
2. Groups:  Investigational
3. Description:  Q-Derp1 is developed by Cytos Biotechnology as an immunodrug. It is an antigen for the prevention of various major chronic diseases. Derp1 is the dominant allergic protein found in dust mite feces.
4. Indication:  Not Available
DrugId:  10
1. Name:  Acremonium strictum
2. Groups:  Approved
3. Description:  Acremonium strictum is a fungus which can provoke allergic reactions. Acremonium strictum extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  11
1. Name:  Helminthosporium solani
2. Groups:  Approved
3. Description:  Helminthosporium solani is a fungus which can provoke allergic reactions. Helminthosporium solani extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  12
1. Name:  Puccinia graminis
2. Groups:  Approved
3. Description:  Puccinia graminis is a fungus which can provoke allergic reactions. Puccinia graminis extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  13
1. Name:  Candida tropicalis
2. Groups:  Approved
3. Description:  Candida tropicalis is a fungus which can provoke allergic reactions. Candida tropicalis is used in allergenic testing.
4. Indication:  Not Available
DrugId:  14
1. Name:  Cochliobolus lunatus
2. Groups:  Approved
3. Description:  Cochliobolus lunatus is a fungus which can provoke allergic reactions. Cochliobolus lunatus extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  15
1. Name:  Haematonectria haematococca
2. Groups:  Approved
3. Description:  Haematonectria haematococca is a fungus which can provoke allergic reactions. Haematonectria haematococca extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  16
1. Name:  Pleospora betae
2. Groups:  Approved
3. Description:  Pleospora betae is a fungus which can provoke allergic reactions. Pleospora betae extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  17
1. Name:  Neurospora sitophila
2. Groups:  Approved
3. Description:  Neurospora sitophila is a fungus which can provoke allergic reactions. Neurospora sitophila extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  18
1. Name:  Aspergillus nidulans
2. Groups:  Approved
3. Description:  Aspergillus nidulans is a fungus which can provoke allergic reactions. Aspergillus nidulans extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  19
1. Name:  Dendryphiella vinosa
2. Groups:  Approved
3. Description:  Dendryphiella vinosa is a fungus which can provoke allergic reactions. Dendryphiella vinosa extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  20
1. Name:  Neurospora intermedia
2. Groups:  Approved
3. Description:  Neurospora intermedia is a fungus which can provoke allergic reactions. Neurospora intermedia extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  21
1. Name:  Eurotium herbariorum
2. Groups:  Approved
3. Description:  Eurotium herbariorum is a fungus which can provoke allergic reactions. Eurotium herbariorum extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  22
1. Name:  Phoma glomerata
2. Groups:  Approved
3. Description:  Phoma glomerata is a fungus which can provoke allergic reactions. Phoma glomerata extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  23
1. Name:  Colletotrichum coccodes
2. Groups:  Approved
3. Description:  Colletotrichum coccodes is a fungus which can provoke allergic reactions. Colletotrichum coccodes extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  24
1. Name:  Voriconazole
2. Groups:  Approved, Investigational
3. Description:  Voriconazole (VfendÂ®, Pfizer) is a triazole antifungal medication used to treat serious fungal infections. It is used to treat invasive fungal infections that are generally seen in patients who are immunocompromised. These include invasive candidiasis, invasive aspergillosis, and emerging fungal infections.
4. Indication:  For the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp.
DrugId:  25
1. Name:  QAV-680
2. Groups:  Investigational
3. Description:  QAV680 has been used in trials studying the treatment of Asthma, Allergic Rhinitis, and Seasonal Allergic Rhinitis.
4. Indication:  Not Available
